Connection

David Potter to Receptors, Opioid, kappa

This is a "connection" page, showing publications David Potter has written about Receptors, Opioid, kappa.
Connection Strength

0.892
  1. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005; 11(2):195-212.
    View in: PubMed
    Score: 0.232
  2. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec; 35(5-6):232-7.
    View in: PubMed
    Score: 0.185
  3. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res. 2001 Aug; 73(2):167-78.
    View in: PubMed
    Score: 0.183
  4. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res. 2000 May; 70(5):675-82.
    View in: PubMed
    Score: 0.167
  5. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology. 2008 Oct; 33(11):2676-87.
    View in: PubMed
    Score: 0.071
  6. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May; 309(2):548-53.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.